Dr. Erin Foster, an Assistant Professor of Dermatology at Oregon Health & Science University, specializes in mucosal dermatology and complex skin disorders. Dr. Foster is recognized for her expertise in treating extramammary Paget’s disease.. Her research explores vulvovaginal mucosal conditions, shared decision-making in healthcare, and the immunological aspects of skin diseases. Dr. Foster practices at the OHSU Dermatology Clinic in Portland, OR.

Dr. Ian Maher is a Professor and Director of Dermatology at the University of Minnesota. He specializes in Mohs surgery, and is board-certified by the American Board of Dermatology. Dr. Maher is also the Mohs Fellowship Director and focuses on teaching and clinical practice.

Dr. Michael A. Marchetti, a dermatologist in Mount Vernon, WA, earned his medical degree from Johns Hopkins University School of Medicine. He previously worked at Memorial Sloan Kettering Cancer Center in New York, NY. With extensive experience in diagnosing and treating skin disorders, including extramammary Paget’s disease (EMPD), he was named a Top Doctor in the New York Metro Area in 2022 and 2023.

Dr. Olushola Akinshemoyin Vaughn, MD (Shola Vaughn) is an Assistant Professor of Dermatology at the Medical College of Wisconsin in Milwaukee. Her interests include vulvar dermatoses in skin of color, transgender skin concerns, and global health. She is the Director of Froedtert’s Mucosal Skin Specialty Clinic for oral and anogenital skin disorders, where she treats patients with extramammary Paget’s Disease. She is also the dermatologist for Froedtert’s Inclusion Health Clinic, the medical home for Milwaukee’s LGBTQ population.

Dr. Mohammed Dany, MD is the director of Mohs and dermatologic surgery at VCU Health in Richmond, VA. Dany is one of only a handful of Mohs surgeons in the greater Richmond area. In addition to Mohs surgery, Dany is also a cutaneous oncologist, treating patients with rare tumors such as Merkle cell carcinoma, sebaceous carcinoma and Dermatofibrosarcoma protuberans.

Dr. Melissa Mauskar, M.D., is an Associate Professor in the Department of Dermatology and the Department of Obstetrics and Gynecology at University of Texas Southwestern Medical Center. Her clinical practice is focused on complex medical dermatology and vulvar dermatoses. She is the founder and Director of the Gynecologic Dermatology Clinic at UT Southwestern, a tertiary referral center for gynecologists, dermatologists, and primary care physicians serving Texas and surrounding states.

Nahid Y. Vidal, M.D., FAAD, FACMS, is a Mohs surgeon with subspecialty expertise in skin cancer treatment and complex reconstruction. Dr. Vidal is also a principal investigator for several clinical studies pertaining to skin cancer and dermatologic surgery, with special interests including rare and complex cutaneous tumors, immunohistochemistry for Mohs surgery, innovation in education, and artificial intelligence.

Professor Tak-Wah Wong MD, PhD works in the Departments of Dermatology, Biochemistry & Molecular Biology, Center of Applied Nanomedicine at National Cheng Kung University in Tainan, Taiwan. He leads a skin cancer team in the University Hospital. He dedicates his research to photobiology, oncology, infectious diseases, wound healing, and abnormal scarring. He is the pioneer of photodynamic therapy (PDT) in Taiwan.

王德華醫師是臺灣台南國立成功大學皮膚科、生物化學和分子生物學系、應用納米醫學中心教授。他在大學醫院領導一個皮膚癌團隊。他的研究致力於光生物學、腫瘤學、傳染病、傷口癒合和異常疤痕。他是臺灣光動力療法（PDT）的先驅。

Dr. Manisha Jashbhai Loss is an associate professor of dermatology at the Johns Hopkins University School of Medicine. A dermatologist who focuses on organ transplant recipients, she launched the mid-Atlantic''s first program solely dedicated to the care of transplant patients. Dr. Loss is a diplomate of the American Board of Dermatology, a founding member of the American Board of Medical Specialties, and an active member of the American Academy of Dermatology..

Dr. Ochoa is an Associate Clinical Professor of Dermatology at the Keck School of Medicine USC. She recently joined the Department of Dermatology at Keck Medicine of USC after 10 years of practice at the UCLA Division of Dermatology.

Dr. Ochoa provides dermatology services for the diagnosis and treatment of a broad range of general skin diseases such as acne, eczema, skin cancer and psoriasis, among others. Her clinical and research interest center around infectious diseases of the skin, including the diagnosis and treatment of patients with skin manifestations of HIV, tropical dermatology (skin infectious diseases acquired abroad) and sexually transmitted diseases.

Dr. Adler is an assistant professor of dermatology at USC and serves as associate director of the USC Environmental Dermatology Unit. His primary clinical and research interests focus on contact dermatitis, a rash that can develop at any point in life due to the numerous substances that come into contact with the skin. He specializes in performing patch testing to diagnose allergic contact dermatitis. He also sees patients with the full range of general and complex skin conditions, with a particular interest in sarcoidosis.

Dr. Mortier Laurent, MD, PhD is a doctor/professor that heads the dermatology division of Huriez University Hospital in Lille, France. Extramammary Paget’s disease (EMPD) patients report that Dr. Laurent is familiar with EMPD diagnosis and treatment.

Dr. Alexander Witkowski is a medical dermatologist specializing in the early detection of skin cancers (particularly melanoma), eczema, seborrheic dermatitis and acne. He completed his medical training and residency in Europe as well as his Ph.D. in Modena (Italy), focused on implementing virtual biopsies with reflectance confocal microscopy and its application to diagnosing melanoma subtypes at the patient bedside.

Min Deng, MD, is the Director of Mohs Micrographic Surgery at MedStar Washington Hospital Center/MedStar Georgetown University Hospital and the only Mohs surgeon employed by MedStar Health. As a board-certified dermatologist and fellowship-trained Mohs surgeon, Dr. Deng has subspecialty expertise in cutaneous oncology, including the diagnosis and management of the most prevalent skin cancers.

Brandon T. Beal, MD is a Board-Certified Dermatologist, and Fellowship trained Mohs Micrographic Surgeon, dermatologic oncologist (cancer doctor of the skin), and facial reconstructive surgeon Dr. Beal completed his dermatology residency at the Cleveland Clinic Dermatology & Plastic Surgery Institute and his fellowship in Mohs Micrographic Surgery, dermatologic oncology, and facial reconstructive surgery at Zitelli & Brodland, PC.

Dr. Ramin Fathi, MD graduated from Illinois Wesleyan University in Bloomington, IL, with a degree in accounting. He then received his medical degree at Rush Medical College in Chicago, IL where he graduated at the top of his medical school class and was inducted into the Alpha Omega Alpha Honor Society. Dr. Fathi is board-certified by the American Board of Dermatology and is an Associate Member of the American College of Mohs Surgery.

Dr. Cristian Navarrete-Dechent, MD is a board certified dermatologist from Santiago, Chile. He works both in clinical practice and as a researcher with his main interests in cutaneous oncology pathogenesis, treatment, and diagnosis. To this end, he uses total body photography, dermoscopy, reflectance confocal microscopy, optical coherence tomography, and artificial intelligence. He currently works in the Department of Dermatology of the Pontificia Universidad Católica de Chile, in Santiago, Chile.

Dr. Catherine Harrell is a board-certified dermatologist with extensive training in medical dermatology, cutaneous oncology, dermatologic surgery, and cosmetic dermatology. Dr. Harrell has a special interest in complex medical dermatology, bullous skin disorders, psoriasis and treatment of skin cancer.

Dr. Pascale Guitera is a Dermatologist, originally from France, specializing in skin tumours. She has completed her PhD in collaboration with the Curie Institute (one of Europe’s leading scientific institutions) on instrumentations for the diagnosis of skin tumours. Dr. Guitera has a particular interest in the technique of in vivo confocal microscopy.

Dr. Anthony M. Rossi, MD is a board certified dermatologist with fellowship training in Mohs Micrographic Surgery and advanced cutaneous oncology at the Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College program. Dr. Rossi treats skin cancers as well as benign skin conditions. Dr. Rossi has specialized training and expertise in dermoscopy and other non-invasive methods of imaging.

Dr. Bradley Merritt, MD is a Dermatologist and Mohs surgeon in Chapel Hill, North Carolina. Dr. Merritt and is highly rated for his expertise skin cancers, including extramammary Paget’s disease (EMPD), and reconstructive urology surgery. Dr. Merritt is an Associate Professor and Clinical Researcher in Dermatology, at University of North Carolina (UNC-Chapel Hill).

Dr. Nicole LeBoeuf is a dermatologist in Worcester, Massachusetts and is affiliated with multiple hospitals in the area, including Brigham and Women's Hospital and Dana-Farber Cancer Institute.

Dr. Otley is professor and chair of the department of dermatology at Mayo Clinic in Rochester, MN. He majored in religion at Williams College, received his medical degree at Duke University, completed a residency in dermatology at Harvard University and then a fellowship in Mohs and Dermatologic Surgery at Mayo Clinic.

Dr. Silvina Pugliese, MD, is a Clinical Assistant Professor of Dermatology and Attending Physician at the Stanford Medicine Outpatient Center and Stanford Cancer Institute. She attended medical school at Boston University and completed her residency at Loma Linda, serving as Chief Resident in her final year. Dr. Pugliese is interested in the management of cutaneous complications associated with chemotherapy, radiation therapy, organ transplantation, and their impact on patient quality of life.

Dr. Sumaira Z. Aasi, M.D., is a Professor of Dermatology and Director of Mohs and Dermatologic Surgery. Dr. Aasi completed a fellowship in Mohs micrographic surgery and cutaneous oncology at Yale University where she was on faculty and served as Associate Chief. Dr. Aasi clinical interests include management of high risk nonmelanoma skin cancers, Mohs histopathology, and reconstructive surgery.

Assistant Professor, Section of Mohs and dermasuregery, Department of Dermatology, Division of Internal Medicine, University of Texas M.D. Anderson Cancer Center, Houston, TX.

Dr. Nicholas L. Compton, MD is a dermatologist who specializes in medical dermatology, including the care of patients with complex skin diseases. He has a special interest in tele-dermatology, using images to diagnose and manage skin disease from a distance, and is developing a program at the University of Washington.

Dr. Erica Lee, MD is a dermatologist who focuses on caring for people with basal cell carcinoma, squamous cell carcinoma, early-stage melanoma, and rare types of skin cancers. Dr. Lee has special training in Mohs surgery, laser surgery, and other dermatologic procedures used to remove skin cancer.

Dr. Matthew R. Livingood is a board-certified dermatologist and co-owner of Arlington Dermatology. Dr. Livingood believes that establishing a strong patient-physician relationship is the cornerstone of effective medical care. He understands that not every patient approaches their skin condition and treatment goals in the same manner and he focuses on finding the specific approach that best serves each of his individual patients.

Dr. Martin Braun, MD is a dermatologist in Washington, DC. He specializes in dermatology and mohs micrographic surgery and is board certified in dermatology. Dr. Braun is a member of the American College of Mohs Surgery, the American Academy of Dermatology, the Washington DC Dermatological Society, and the American Society of Dermatologic Surgery.

Dr. Rachel Ware Miller, MD is an assistant professor of gynecologic oncology at the University of Kentucky Markey Cancer Center in Lexington, KY. Dr. Miller’s research interests include early detection of ovarian cancer, novel strategies in the treatment of ovarian cancer, chemotherapy-induced cognitive impairment, radical pelvic surgery, and robotic surgery for gynecologic cancers.

Dr. Thanh Dellinger, MD, is a gynecologic oncologist with specialized training in robotic-assisted (minimally invasive) surgery for uterine and cervical cancer, which can be as effective as traditional surgery but with reduced scarring, pain and recovery time. Dr. Dellinger is also an expert in advanced cytoreductive surgery for ovarian cancer, which can significantly improve survival outcomes for patients. Additionally, Dr. Dellinger has specialized training in PIPAC, a novel drug delivery method for recurrent ovarian cancer patients.

Dr. Melissa Mauskar, M.D., is an Associate Professor in the Department of Dermatology and the Department of Obstetrics and Gynecology at University of Texas Southwestern Medical Center. Her clinical practice is focused on complex medical dermatology and vulvar dermatoses. She is the founder and Director of the Gynecologic Dermatology Clinic at UT Southwestern, a tertiary referral center for gynecologists, dermatologists, and primary care physicians serving Texas and surrounding states.

Dr. Michaela Onstad Grinsfelder, MD is assistant professor in the department of Gynecologic Oncology and Reproductive Medicine (Division of Surgery) at the University of Texas MD Anderson Cancer Center, in Houston, TX. Dr. Grinsfelder received a Master of Public Health and her Doctor of Medicine degrees from the University of California Davis School of Medicine in Sacramento, CA.

Dr. Bill Cliby is an obstetrician-gynecologist at the with Mayo Clinic in Rochester, MN. He received his medical degree from The Robert Larner, M.D. College of Medicine at The University of Vermont. Dr. Cliby focuses on gynecologic cancers and reconstructive surgery.

As a gynecologic oncologist, Dr. Rachel Ruskin provides specialized care for women with ovarian, uterine, cervical, vaginal, and vulvar cancer. She personalizes each patient’s treatment plan through a variety of surgical approaches, chemotherapy regimens, and targeted agents.

Dr. Joseph Ivy is dedicated to providing compassionate, effective care for female cancer patients and their families. He passionately believes that cancer care should focus on providing the best possible quality of life and chance of recovery for his patients. Dr. Ivy uses minimally invasive techniques whenever possible in his surgical practice.

Dr. Janiel Cragun is an Assistant Professor in the Department of Obstetrics and Gynecology at the University of Arizona. She is fellowship-trained in the specialty of gynecology oncology. Dr. Cragun offers surgical interventions to include both radical and minimally invasive procedures. She also offers chemotherapeutic and palliative interventions.

Gynecologist-obstetrician, Dr. Patrice Mathevet is an expert in gynecological cancers and more particularly in the surgical treatment of pelvic cancers. He was appointed full professor of UNIL and chief physician of the Department of Gynecology of CHUV from 1 October 2013.

Tyler Ford, MD, is a gynecologic oncologist in Richmond, VA. Dr. Ford earned his medical degree from Albany Medical College and completed a residency in obstetrics and gynecology at Albany Medical Center in Albany, NY. Dr. Ford’s specialties include minimally-invasive surgical techniques treating specific gynecologic cancers, as well as clinical research.

The research involvement and interests of Dr. Jamie N. Bakkum-Gamez, MD, include screening and early detection modalities in ovarian cancer and endometrial cancer; prognostic molecular markers in ovarian cancer and endometrial cancer; and quality improvement in postoperative outcomes after ovarian cancer staging surgery.

Dr. Eloise Chapman-Davis' mission is to provide the highest standards of care in prevention, diagnosis and treatment of gynecologic cancers by incorporating the latest surgical approaches and practicing evidence based medicine. Dr. Chapman-Davis' practice promotes compassionate care with a focus on empowering women to be active participants in decision making regarding their health care.

Dr. Oliver Dorigo, MD, PHD is an Associate Professor of Obstetrics and Gynecology (Oncology) at the Stanford University Medical Center in Palo Alto, CA. Dr. Dorigo’s clinical focus is the treatment of patients with gynecologic cancers, including ovarian, cervical, endometrial, vaginal and vulva cancer. In his surgical practice, Dr. Dorigo is emphasizing the use of minimal invasive technologies in particular laparoscopic and robotic surgery.

Dr. Richard J. Cardosi, MD is a Gynecologic Oncologist at Watson Clinic located in Lakeland, FL.

Dr. Hoffman is a world-renowned expert in the surgical management of gynecologic cancers and other complex gynecologic disorders. He has over 30 years of surgical experience, has published extensively on all aspects of female cancer surgery, and has lectured around the world on these subjects. Dr. Hoffman was voted by physician peers as one of the top gynecologic oncologists (Tampa Magazine, 2017).

Dr. Alpa M. Nick is a board certified gynecologic oncologist. Dr. Nick received her medical degree from Louisiana State University Health Sciences Center, and completed her gynecologic oncology fellowship at the University of Texas MD Anderson Cancer Center in Houston, TX.

Dr. Mario M. Leitao, Jr., MD is a board-certified gynecologic oncologist who specializes in surgery for women with ovarian, endometrial, cervical, vulvar, or vaginal cancer. Dr. Leitao, Jr. has a strong interest in providing minimally invasive surgical options for our patients, including both laparoscopic and robotic-assisted procedures. He joined the Memorial Sloan Kettering staff in 2007.

Edward Tanner, M.D., is a professor of gynecologic oncology in the Johns Hopkins Medicine Department of Gynecology and Obstetrics and the medical director for women’s health in the Johns Hopkins National Capital Region. Dr. Tanner is an internationally recognized expert in gynecologic surgery and is known for his surgical skills, compassionate bedside manner, leadership and teaching abilities.

Dr. Bridgette Duggan, MD is dedicated to the comprehensive care and treatment of women diagnosed with gynecologic cancers, pre-cancerous conditions and complex problems that require the specialized training and experience of a gynecologic oncologist.

Dr. Thanh Dellinger, MD, is a gynecologic oncologist with specialized training in robotic-assisted (minimally invasive) surgery for uterine and cervical cancer, which can be as effective as traditional surgery but with reduced scarring, pain and recovery time. Dr. Dellinger is also an expert in advanced cytoreductive surgery for ovarian cancer, which can significantly improve survival outcomes for patients. Additionally, Dr. Dellinger has specialized training in PIPAC, a novel drug delivery method for recurrent ovarian cancer patients.

A medical oncologist, Dawn Klemow-Reed, M.D., specializes in the areas of breast cancer and benign hematology. Her primary emphasis is determining therapeutic approaches to eliminate cancer cells and prevent their spread throughout the body. Based on her experience and knowledge of new breast cancer therapeutics, Dr. Klemow-Reed offers a comprehensive range of treatment options to patients. This includes both traditional and new alternatives – chemotherapy drugs, biologic agents, and hormonal therapy. Her expertise includes presenting alternatives with less toxicity than conventional chemotherapy.

Dr. Cristian Navarrete-Dechent, MD is a board certified dermatologist from Santiago, Chile. He works both in clinical practice and as a researcher with his main interests in cutaneous oncology pathogenesis, treatment, and diagnosis. To this end, he uses total body photography, dermoscopy, reflectance confocal microscopy, optical coherence tomography, and artificial intelligence. He currently works in the Department of Dermatology of the Pontificia Universidad Católica de Chile, in Santiago, Chile.

Dr. Christopher Ryan specializes in the treatment of sarcomas (rare bone and soft tissue tumors) and genitourinary cancers (kidney, bladder, prostate and testicle cancers). He strives to offer the latest treatments to his patients through clinical trials. He is inspired by his many patients who received breakthrough treatments in clinical trials before those treatments were widely available.

Dr. Theresa Medina specializes in Internal Medicine and Medical Oncology at the University of Colorado Cancer Center in Aurora, CO and has experience treating extramammary Paget’s disease (EMPD) patients.

Dr. Bill Cliby is an obstetrician-gynecologist at the with Mayo Clinic in Rochester, MN. He received his medical degree from The Robert Larner, M.D. College of Medicine at The University of Vermont. Dr. Cliby focuses on gynecologic cancers and reconstructive surgery.

Phillip Devlin, MD, FACR is Associate Professor of Radiation Oncology at Harvard Medical School and Chief of the Division of Brachytherapy in the Department of Radiation Oncology at the Dana-Farber/Brigham and Women’s Cancer Center. He earned his medical degree at the University of Virginia School of Medicine in 1991 and completed his residency in Radiation Oncology at the University of Pennsylvania in 1995, followed by a specialized fellowship in brachytherapy at Memorial Sloan-Kettering Cancer Center in 1996.

Dr. Sophie Dessureault is a surgical oncologist in the Department of Gastrointestinal Oncology at Moffitt Cancer Center. She is a professor of oncology and surgery at the University of South Florida Morsani College of Medicine. Dr. Dessureault is widely published and is a member of numerous professional organizations.

As a gynecologic oncologist, Dr. Rachel Ruskin provides specialized care for women with ovarian, uterine, cervical, vaginal, and vulvar cancer. She personalizes each patient’s treatment plan through a variety of surgical approaches, chemotherapy regimens, and targeted agents.

Dr. Joseph Ivy is dedicated to providing compassionate, effective care for female cancer patients and their families. He passionately believes that cancer care should focus on providing the best possible quality of life and chance of recovery for his patients. Dr. Ivy uses minimally invasive techniques whenever possible in his surgical practice.

Dr. Janiel Cragun is an Assistant Professor in the Department of Obstetrics and Gynecology at the University of Arizona. She is fellowship-trained in the specialty of gynecology oncology. Dr. Cragun offers surgical interventions to include both radical and minimally invasive procedures. She also offers chemotherapeutic and palliative interventions.

Lance C. Pagliaro, M.D., conducts research in kidney, prostate, bladder, testicular and penile cancers. Dr. Pagliaro specializes in the medical treatment of these conditions using immuno-oncology drugs and other targeted therapies.

Dr. Silvina Pugliese, MD, is a Clinical Assistant Professor of Dermatology and Attending Physician at the Stanford Medicine Outpatient Center and Stanford Cancer Institute. She attended medical school at Boston University and completed her residency at Loma Linda, serving as Chief Resident in her final year. Dr. Pugliese is interested in the management of cutaneous complications associated with chemotherapy, radiation therapy, organ transplantation, and their impact on patient quality of life.

Dr. Sumaira Z. Aasi, M.D., is a Professor of Dermatology and Director of Mohs and Dermatologic Surgery. Dr. Aasi completed a fellowship in Mohs micrographic surgery and cutaneous oncology at Yale University where she was on faculty and served as Associate Chief. Dr. Aasi clinical interests include management of high risk nonmelanoma skin cancers, Mohs histopathology, and reconstructive surgery.

Dr. Alexander R. Miller is an experienced surgical oncologist specializing in breast cancer, skin cancer (melanoma), pancreatic and gastric cancer, as well as sarcoma. He has devoted his career to cancer research, education and treatment.

Dr. Doug McKay is an Assistant Professor with the Department of Surgery at Queen's University. Dr. McKay has been an Attending Staff member at both Kingston General Hospital and Hotel Dieu Hospital since 2010. Dr. McKay is clinically interested in the cleft lip and palate, oncological reconstruction, and plastic surgery in general.

Dr. Eloise Chapman-Davis' mission is to provide the highest standards of care in prevention, diagnosis and treatment of gynecologic cancers by incorporating the latest surgical approaches and practicing evidence based medicine. Dr. Chapman-Davis' practice promotes compassionate care with a focus on empowering women to be active participants in decision making regarding their health care.

Dr. Richard J. Cardosi, MD is a Gynecologic Oncologist at Watson Clinic located in Lakeland, FL.

Dr. Hoffman is a world-renowned expert in the surgical management of gynecologic cancers and other complex gynecologic disorders. He has over 30 years of surgical experience, has published extensively on all aspects of female cancer surgery, and has lectured around the world on these subjects. Dr. Hoffman was voted by physician peers as one of the top gynecologic oncologists (Tampa Magazine, 2017).

In addition to his clinical practice, Dr. Mukul Gupta, MD is an accomplished researcher. He has studied treatments for lymphoma and carcinoma; his research has appeared in the American Journal of Physiology, American Pediatric Society Journal, and American Society of Clinical Oncology Journal.

Dr. Alpa M. Nick is a board certified gynecologic oncologist. Dr. Nick received her medical degree from Louisiana State University Health Sciences Center, and completed her gynecologic oncology fellowship at the University of Texas MD Anderson Cancer Center in Houston, TX.

Dr. Mario M. Leitao, Jr., MD is a board-certified gynecologic oncologist who specializes in surgery for women with ovarian, endometrial, cervical, vulvar, or vaginal cancer. Dr. Leitao, Jr. has a strong interest in providing minimally invasive surgical options for our patients, including both laparoscopic and robotic-assisted procedures. He joined the Memorial Sloan Kettering staff in 2007.

Edward Tanner, M.D., is a professor of gynecologic oncology in the Johns Hopkins Medicine Department of Gynecology and Obstetrics and the medical director for women’s health in the Johns Hopkins National Capital Region. Dr. Tanner is an internationally recognized expert in gynecologic surgery and is known for his surgical skills, compassionate bedside manner, leadership and teaching abilities.

Evan J. Lipson, M.D., is a medical oncologist at the Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital, as well as an assistant professor of oncology at Johns Hopkins University School of Medicine. Dr. Lipson established the Johns Hopkins Melanoma Program at Sibley in 2012 and opened the program's first clinical trial in the Washington, D.C. region in 2015. He is board certified in internal medicine and medical oncology. 

Dr. Lipson has an expertise in melanoma and treatment of patients with cutaneous malignancies, specifically regarding the use of novel immunotherapies. 

Dr. Bridgette Duggan, MD is dedicated to the comprehensive care and treatment of women diagnosed with gynecologic cancers, pre-cancerous conditions and complex problems that require the specialized training and experience of a gynecologic oncologist.

Dr. Viraj Master, MD is a Professor of Urology at the Emory University School of Medicine, Associate Chair for Clinical Affairs and Quality, and Director of Clinical Research Unit. Dr. Master’s primary clinical interest is urologic oncology, in particular kidney cancer, adrenal tumors, testicular cancer, high-risk prostate cancer and penile cancers.

Assistant Professor, Section of Mohs and dermasuregery, Department of Dermatology, Division of Internal Medicine, University of Texas M.D. Anderson Cancer Center, Houston, TX.

Dr. Yélamos is European Board Certified Dermatologist and Venereologist (UEMS-EBDV), currently working at Hospital Clínic, Barcelona (Spain) and Hospital Teknon-Quirónsalud, Barcelona (Spain) where he combines research activities with patient care. He is also studying the impact of in vivo reflectance confocal microscopy in guiding surgery and topical treatments in dermatology.

Dr. Lee is the Director of the Pigmented Lesion Clinical at Thomas Jefferson University in Philadelphia, PA. The clinic offers full body clinical examination, dermatoscopy, excisional biopsies of suspicious lesions and histopathologic examination including review of any relevant past biopsy specimens.

Phillip Devlin, MD, FACR is Associate Professor of Radiation Oncology at Harvard Medical School and Chief of the Division of Brachytherapy in the Department of Radiation Oncology at the Dana-Farber/Brigham and Women’s Cancer Center. He earned his medical degree at the University of Virginia School of Medicine in 1991 and completed his residency in Radiation Oncology at the University of Pennsylvania in 1995, followed by a specialized fellowship in brachytherapy at Memorial Sloan-Kettering Cancer Center in 1996.

Dr. Yélamos is European Board Certified Dermatologist and Venereologist (UEMS-EBDV), currently working at Hospital Clínic, Barcelona (Spain) and Hospital Teknon-Quirónsalud, Barcelona (Spain) where he combines research activities with patient care. He is also studying the impact of in vivo reflectance confocal microscopy in guiding surgery and topical treatments in dermatology.

Dr. McNally is a surgical oncologist specializing in colorectal cancers and complex malignancies. Graduating from the University of Missouri-Kansas City's BLA-MD program in 2005, she completed her general surgery residency at Truman Medical Centers and Saint Luke's Hospital in 2010, followed by fellowship training in surgical oncology. Board-certified by the American Board of Surgery and a fellow of the Society of Surgical Oncology, Dr. McNally earned a Master's in Medical Science from The Ohio State University, focusing on bioinformatic approaches to cholangiocarcinoma. She joined Saint Luke's Health System in 2012.

Dr. Ian Maher is a Professor and Director of Dermatology at the University of Minnesota. He specializes in Mohs surgery, and is board-certified by the American Board of Dermatology. Dr. Maher is also the Mohs Fellowship Director and focuses on teaching and clinical practice.

Dr. Jon Stuart Hourigan, MD, FACS, FASCRS was born and raised in Bowling Green, Kentucky. Dr. Hourigan’s clinical interests include the comprehensive treatment of colon cancer and rectal cancer, surgical management of inflammatory bowel disease and diverticulitis, and the treatment of benign anorectal disorders. He is an expert in both traditional and minimally invasive approaches for colon and rectal diseases.

Dr. Thanh Dellinger, MD, is a gynecologic oncologist with specialized training in robotic-assisted (minimally invasive) surgery for uterine and cervical cancer, which can be as effective as traditional surgery but with reduced scarring, pain and recovery time. Dr. Dellinger is also an expert in advanced cytoreductive surgery for ovarian cancer, which can significantly improve survival outcomes for patients. Additionally, Dr. Dellinger has specialized training in PIPAC, a novel drug delivery method for recurrent ovarian cancer patients.

Dr. Mohammed Dany, MD is the director of Mohs and dermatologic surgery at VCU Health in Richmond, VA. Dany is one of only a handful of Mohs surgeons in the greater Richmond area. In addition to Mohs surgery, Dany is also a cutaneous oncologist, treating patients with rare tumors such as Merkle cell carcinoma, sebaceous carcinoma and Dermatofibrosarcoma protuberans.

Dr. Vitaly Margulis, MD, Professor of Urology at UT Southwestern Medical Center, graduated with honors from the University of Texas at Austin and UT Southwestern Medical School. He trained in the highly competitive urology residency program at UT Southwestern and completed a fellowship in urologic oncology at the University of Texas MD Anderson Cancer Center in Houston, where he was previously a Clinical Specialist in Urologic Oncology. An expert surgeon, Dr. Margulis uses minimally invasive techniques to treat patients with soft-tissue tumors and kidney, prostate, bladder, testicular, penile, and adrenal cancers.

Nahid Y. Vidal, M.D., FAAD, FACMS, is a Mohs surgeon with subspecialty expertise in skin cancer treatment and complex reconstruction. Dr. Vidal is also a principal investigator for several clinical studies pertaining to skin cancer and dermatologic surgery, with special interests including rare and complex cutaneous tumors, immunohistochemistry for Mohs surgery, innovation in education, and artificial intelligence.

Dr. Robert Caleb Kovell, MD is a board-certified urologist focused on providing individualized care for patients while helping them understand their options and achieve their goals. His practice, at Penn Medicine in Philadelphia, focuses on reconstructive urology which includes improving urologic function when it has been compromised by trauma, congenital urologic conditions, cancer, previous surgery or radiation therapy.

Dr. Philip Iorianni, MD is a board-certified plastic surgeon working with the Mid-Atlantic Permanente Medical Group based in Kensington, Maryland. Dr. Iorianni received his medical education from the George Washington University School of Medicine and Health Sciences in Washington, DC.

Dr. Philippe Spiess is a genitourinary oncologist and the assistant chief of surgical services at the Moffitt Cancer Center. He is well a full professor of oncology and urology at the University of South Florida Morsani College of Medicine. Prior to joining Moffitt, Dr. Spiess completed a three-year SUO-accredited urologic oncology fellowship at the MD Anderson Cancer Center in Houston, TX.

Min Deng, MD, is the Director of Mohs Micrographic Surgery at MedStar Washington Hospital Center/MedStar Georgetown University Hospital and the only Mohs surgeon employed by MedStar Health. As a board-certified dermatologist and fellowship-trained Mohs surgeon, Dr. Deng has subspecialty expertise in cutaneous oncology, including the diagnosis and management of the most prevalent skin cancers.

Brandon T. Beal, MD is a Board-Certified Dermatologist, and Fellowship trained Mohs Micrographic Surgeon, dermatologic oncologist (cancer doctor of the skin), and facial reconstructive surgeon Dr. Beal completed his dermatology residency at the Cleveland Clinic Dermatology & Plastic Surgery Institute and his fellowship in Mohs Micrographic Surgery, dermatologic oncology, and facial reconstructive surgery at Zitelli & Brodland, PC.

Dr. Ramin Fathi, MD graduated from Illinois Wesleyan University in Bloomington, IL, with a degree in accounting. He then received his medical degree at Rush Medical College in Chicago, IL where he graduated at the top of his medical school class and was inducted into the Alpha Omega Alpha Honor Society. Dr. Fathi is board-certified by the American Board of Dermatology and is an Associate Member of the American College of Mohs Surgery.

Dr. Catherine Harrell is a board-certified dermatologist with extensive training in medical dermatology, cutaneous oncology, dermatologic surgery, and cosmetic dermatology. Dr. Harrell has a special interest in complex medical dermatology, bullous skin disorders, psoriasis and treatment of skin cancer.

Dr. Anthony M. Rossi, MD is a board certified dermatologist with fellowship training in Mohs Micrographic Surgery and advanced cutaneous oncology at the Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College program. Dr. Rossi treats skin cancers as well as benign skin conditions. Dr. Rossi has specialized training and expertise in dermoscopy and other non-invasive methods of imaging.

Dr. Bryan Voelzke, MD, MS, FACS, is a board certified urologist at Spokane Urology. Dr. Voelzke prior academic practice was solely devoted to reconstructive urology at the University of Washington/Harborview Medical Center in Seattle. Dr. Voelzke has received a number of awards from patients in recognition of his attention to patient care.

Brad Figler received his medical degree from Case Western Reserve University School of Medicine and completed his residency training in Urology at Emory University Hospital in Atlanta, GA. After his fellowship training, Dr. Figler worked at Thomas Jefferson University in Philadelphia as Assistant Professor of Urology and Director of Reconstructive Urology. Dr. Figler serves as fellowship faculty for the UNC Urology Men's Health Fellowship.

Dr. Bradley Merritt, MD is a Dermatologist and Mohs surgeon in Chapel Hill, North Carolina. Dr. Merritt and is highly rated for his expertise skin cancers, including extramammary Paget’s disease (EMPD), and reconstructive urology surgery. Dr. Merritt is an Associate Professor and Clinical Researcher in Dermatology, at University of North Carolina (UNC-Chapel Hill).

Dr. Sophie Dessureault is a surgical oncologist in the Department of Gastrointestinal Oncology at Moffitt Cancer Center. She is a professor of oncology and surgery at the University of South Florida Morsani College of Medicine. Dr. Dessureault is widely published and is a member of numerous professional organizations.

Dr. Paul Chung is a Jefferson University urology physician with experience in genitourinary reconstruction and extramammary Paget's disease (EMPD) treatment in men. Dr. Chung is a Sidney Kimmel Medical College, at Thomas Jefferson University Medical School, graduate. Dr. Chung had an internship and residency at University of Texas Southwestern and a fellowship at University of Washington in Seattle, WA.

Dr. Joseph Ivy is dedicated to providing compassionate, effective care for female cancer patients and their families. He passionately believes that cancer care should focus on providing the best possible quality of life and chance of recovery for his patients. Dr. Ivy uses minimally invasive techniques whenever possible in his surgical practice.

Dr. Janiel Cragun is an Assistant Professor in the Department of Obstetrics and Gynecology at the University of Arizona. She is fellowship-trained in the specialty of gynecology oncology. Dr. Cragun offers surgical interventions to include both radical and minimally invasive procedures. She also offers chemotherapeutic and palliative interventions.

Gynecologist-obstetrician, Dr. Patrice Mathevet is an expert in gynecological cancers and more particularly in the surgical treatment of pelvic cancers. He was appointed full professor of UNIL and chief physician of the Department of Gynecology of CHUV from 1 October 2013.

Tyler Ford, MD, is a gynecologic oncologist in Richmond, VA. Dr. Ford earned his medical degree from Albany Medical College and completed a residency in obstetrics and gynecology at Albany Medical Center in Albany, NY. Dr. Ford’s specialties include minimally-invasive surgical techniques treating specific gynecologic cancers, as well as clinical research.

The research involvement and interests of Dr. Jamie N. Bakkum-Gamez, MD, include screening and early detection modalities in ovarian cancer and endometrial cancer; prognostic molecular markers in ovarian cancer and endometrial cancer; and quality improvement in postoperative outcomes after ovarian cancer staging surgery.

Dr. Curtis Pettaway is an urologist in Houston, Texas and is affiliated with University of Texas MD Anderson Cancer Center. He received his medical degree from Temple University School of Medicine and has been in practice for more than 20 years. Dr. Pettaway is one of 18 doctors at University of Texas MD Anderson Cancer Center who specialize in Urology.

Dr. Otley is professor and chair of the department of dermatology at Mayo Clinic in Rochester, MN. He majored in religion at Williams College, received his medical degree at Duke University, completed a residency in dermatology at Harvard University and then a fellowship in Mohs and Dermatologic Surgery at Mayo Clinic.

Dr. Sumaira Z. Aasi, M.D., is a Professor of Dermatology and Director of Mohs and Dermatologic Surgery. Dr. Aasi completed a fellowship in Mohs micrographic surgery and cutaneous oncology at Yale University where she was on faculty and served as Associate Chief. Dr. Aasi clinical interests include management of high risk nonmelanoma skin cancers, Mohs histopathology, and reconstructive surgery.

Dr. Alexander R. Miller is an experienced surgical oncologist specializing in breast cancer, skin cancer (melanoma), pancreatic and gastric cancer, as well as sarcoma. He has devoted his career to cancer research, education and treatment.

Assistant Professor, Section of Mohs and dermasuregery, Department of Dermatology, Division of Internal Medicine, University of Texas M.D. Anderson Cancer Center, Houston, TX.

Dr. Vitaly Margulis, MD, Professor of Urology at UT Southwestern Medical Center, graduated with honors from the University of Texas at Austin and UT Southwestern Medical School. He trained in the highly competitive urology residency program at UT Southwestern and completed a fellowship in urologic oncology at the University of Texas MD Anderson Cancer Center in Houston, where he was previously a Clinical Specialist in Urologic Oncology. An expert surgeon, Dr. Margulis uses minimally invasive techniques to treat patients with soft-tissue tumors and kidney, prostate, bladder, testicular, penile, and adrenal cancers.

Dr. Robert Caleb Kovell, MD is a board-certified urologist focused on providing individualized care for patients while helping them understand their options and achieve their goals. His practice, at Penn Medicine in Philadelphia, focuses on reconstructive urology which includes improving urologic function when it has been compromised by trauma, congenital urologic conditions, cancer, previous surgery or radiation therapy.

Dr. Philippe Spiess is a genitourinary oncologist and the assistant chief of surgical services at the Moffitt Cancer Center. He is well a full professor of oncology and urology at the University of South Florida Morsani College of Medicine. Prior to joining Moffitt, Dr. Spiess completed a three-year SUO-accredited urologic oncology fellowship at the MD Anderson Cancer Center in Houston, TX.

Dr. Bryan Voelzke, MD, MS, FACS, is a board certified urologist at Spokane Urology. Dr. Voelzke prior academic practice was solely devoted to reconstructive urology at the University of Washington/Harborview Medical Center in Seattle. Dr. Voelzke has received a number of awards from patients in recognition of his attention to patient care.

Brad Figler received his medical degree from Case Western Reserve University School of Medicine and completed his residency training in Urology at Emory University Hospital in Atlanta, GA. After his fellowship training, Dr. Figler worked at Thomas Jefferson University in Philadelphia as Assistant Professor of Urology and Director of Reconstructive Urology. Dr. Figler serves as fellowship faculty for the UNC Urology Men's Health Fellowship.

Dr. Paul Chung is a Jefferson University urology physician with experience in genitourinary reconstruction and extramammary Paget's disease (EMPD) treatment in men. Dr. Chung is a Sidney Kimmel Medical College, at Thomas Jefferson University Medical School, graduate. Dr. Chung had an internship and residency at University of Texas Southwestern and a fellowship at University of Washington in Seattle, WA.

Dr. Wilson is an Associate Professor at the University of Colorado Denver. Dr. Wilson was the first woman to join the Urologic faculty at the University. She is subspecialty trained in Oncology and is further subspecialty trained in robotic surgery. Dr. Wilson's interests include bladder, kidney, prostate, testicular, and penile cancer. She is also actively involved in clinical and basic science research to improve outcomes in patients diagnosed with genitourinary malignancy.

Dr. Curtis Pettaway is an urologist in Houston, Texas and is affiliated with University of Texas MD Anderson Cancer Center. He received his medical degree from Temple University School of Medicine and has been in practice for more than 20 years. Dr. Pettaway is one of 18 doctors at University of Texas MD Anderson Cancer Center who specialize in Urology.

Dr. Jason D. Engel is a urologist affiliated with Sibley Memorial Hospital and George Washington University Hospital, where he is the director of urologic robotic surgery and a clinical associate professor. Dr. Engel is certified in urology by the American Board of Urology. He practices out of Urologic Surgeons of Washington in Washington, D.C.

Dr. Viraj Master, MD is a Professor of Urology at the Emory University School of Medicine, Associate Chair for Clinical Affairs and Quality, and Director of Clinical Research Unit. Dr. Master’s primary clinical interest is urologic oncology, in particular kidney cancer, adrenal tumors, testicular cancer, high-risk prostate cancer and penile cancers.

Dr. Hadley Wyre, MD, is an Assistant Professor of Urology at The University of Kansas Cancer Center - South. Dr. Wyre earned his medical degree from Emory University in Atlanta, GA. He completed both a urology residency and fellowship in Trauma / Reconstructive Urology from Emery University as well.